ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
New Board of Directors and management team at Suven Pharma also appointed
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Clindamycin Phosphate Gel is used to treat acne
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
The product is expected to start contributing meaningfully to the revenue from FY25
Subscribe To Our Newsletter & Stay Updated
